文献速递泌尿系感染前列腺增生与排尿功能障碍

诱发的尿白细胞介素-6与非发热性下尿路感染症状严重程度相关

Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections.
PubMed 文献 · J Urol · 2017-02-01

本研究纳入因脊柱病变导致残余尿和神经源性膀胱、并参与长期大肠埃希菌83972无症状菌尿接种试验的患者,随访2年,定期进行症状评分和尿液采样检测白细胞介素-6、白细胞介素-8及中性粒细胞。共记录37次非发热性尿路感染发作,白细胞介素-6是唯一在尿路感染期间持续升高的标志物,且白细胞介素-6高于25 ng/l与更严重的尿路感染症状相关。作者认为诱发的白细胞介素-6有望鉴别尿路感染与无症状菌尿。

要点

  • 在神经源性膀胱患者中,白细胞介素-6是唯一在非发热性尿路感染期间持续升高的标志物。
  • 白细胞介素-6高于25 ng/l与更严重的尿路感染症状相关。
  • 所有标志物鉴别无症状菌尿与所有尿路感染发作的敏感性和特异性为差/中等。

核心结论

  • 诱发的白细胞介素-6与尿路感染症状严重程度相关,并显示出有前景的鉴别尿路感染与无症状菌尿的能力。
  • 未来研究应探索白细胞介素-6作为尿路感染严重程度标志物,并评估非发热性尿路感染的治疗指征。

研究设计与样本

  • 纳入因脊柱病变导致残余尿和神经源性膀胱、并参与长期大肠埃希菌83972无症状菌尿接种试验的患者,随访2年。
  • 定期每月及尿路感染发作时进行症状评分和尿液采样,检测白细胞介素-6、白细胞介素-8及中性粒细胞。

主要发现

  • 患者在整个研究中平均随访19个月(范围10至27个月),其中大肠埃希菌83972无症状菌尿患者平均随访11个月(范围4至19个月)。
  • 共记录37次非发热性尿路感染发作,具有白细胞介素-6、白细胞介素-8、中性粒细胞和症状评分的完整数据。
  • 在合并和个体内配对比较中,白细胞介素-6是唯一在尿路感染期间持续高于无症状菌尿的标记物(p <0.05)。
  • 白细胞介素-6高于阈值(大于25 ng/l)与更严重的尿路感染症状相关(p <0.05)。
  • 所有生物标志物在区分无症状菌尿与所有尿路感染发作时的敏感性和特异性为差/中等;但在症状更严重的尿路感染中,白细胞介素-6和中性粒细胞表现出同等良好/优秀的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Objective diagnosis of symptomatic urinary tract infections in patients prone to asymptomatic bacteriuria is compromised by local host responses that are already present and the positive urine culture. We investigated interleukin-6 as a biomarker for nonfebrile urinary tract infection severity and diagnostic thresholds for interleukin-6 and 8, and neutrophils to differentiate between asymptomatic bacteriuria and urinary tract infection. MATERIALS AND METHODS: Patients with residual urine and neurogenic bladders due to spinal lesions included in a long-term Escherichia coli 83972 asymptomatic bacteriuria inoculation trial were monitored for 2 years. Symptom scoring and urine sampling to estimate interleukin-6 and 8, and neutrophils were performed regularly monthly and at urinary tract infection episodes. RESULTS: Patients were followed in the complete study for a mean of 19 months (range 10 to 27) and those with asymptomatic bacteriuria with E. coli 83972 were followed a mean of 11 months (range 4 to 19). A total of 37 nonfebrile urinary tract infection episodes with complete data on interleukin-6 and 8, neutrophils and symptom scoring were documented. Interleukin-6 was the only marker that persistently increased during urinary tract infection compared to asymptomatic bacteriuria in pooled and paired intra-individual comparisons (p <0.05). Interleukin-6 above the threshold (greater than 25 ng/l) correlated to more severe urinary tract infection symptoms (p <0.05). The sensitivity and specificity of all biomarkers were poor/moderate when differentiating asymptomatic bacteriuria vs all urinary tract infection episodes. However, in urinary tract infections with worse symptoms interleukin-6 and neutrophils demonstrated equal good/excellent outcomes. CONCLUSIONS: Triggered interleukin-6 correlated to urinary tract infection symptom severity and demonstrated a promising differential diagnostic capacity to discriminate urinary tract infection from asymptomatic bacteriuria. Future studies should explore interleukin-6 as a biomarker of urinary tract infection severity and assess the treatment indication in nonfebrile urinary tract infections.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Sundén F, Butler D, Wullt B, et al. Triggered Urine Interleukin-6 Correlates to Severity of Symptoms in Nonfebrile Lower Urinary Tract Infections. J Urol. 2017. PMID: 28161350. doi:10.1016/j.juro.2017.01.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。